neoplasm
|
• after treatment with the genotoxic bladder carcinogen BBN, no null females develop carcinomas whereas 42% of treated females have bladder carcinomas by 40 weeks post-treatment
|
preneoplasia
(
J:120844
)
|
• only 2 females display preneoplastic lesions (hyperplasias) of the bladder by 40 weeks following treatment compared to 67% of wild-type females
|
homeostasis/metabolism
|
• after treatment with the genotoxic bladder carcinogen BBN, no null females develop carcinomas whereas 42% of treated females have bladder carcinomas by 40 weeks post-treatment
|